These are not supplements chosen because they sound credible. Every compound below has a documented mechanism, studied doses, and a specific rationale tied to the withdrawal biology above.
N-Acetylcysteine (NAC)
600mg twice daily
Glutamate homeostasis restoration
NAC restores function of the cystine-glutamate antiporter (system xCT) in the nucleus accumbens. Substance use suppresses this transporter, causing pathological glutamate signaling that drives compulsive use behavior.
WHY THIS SUBSTANCE
Every substance studied here - nicotine, cannabis, and alcohol - dysregulates the glutamate system. NAC is the only compound with evidence across all three. It also provides hepatoprotection directly relevant to alcohol recovery.
Three randomized controlled trials show NAC reduces cannabis use and craving. One double-blind RCT showed significant reduction in tobacco use. NAC is the primary treatment for acetaminophen-induced liver failure - its hepatoprotective mechanism is among the most studied in clinical medicine.
Cytisine
1.5mg, titrated schedule
Partial agonist at alpha4beta2 nAChRs
Cytisine occupies nicotinic acetylcholine receptors with lower intrinsic activity than nicotine. It reduces craving by partially satisfying receptor signaling while blocking nicotine's full reward effect if relapse occurs. The mechanism is identical to varenicline (Chantix) but cytisine is plant-derived.
WHY THIS SUBSTANCE
nAChR upregulation is the defining mechanism of nicotine addiction. Cytisine directly addresses this mechanism at the receptor level rather than managing symptoms downstream.
Cytisine has been used as a cessation aid in Eastern Europe since the 1960s. A 2011 New England Journal of Medicine trial found it more effective than nicotine replacement therapy. It remains largely unknown in the US market.
Omega-3 DHA/EPA
2000mg (EPA 180mg + DHA 120mg)
Endocannabinoid substrate restoration
The brain's endocannabinoids - anandamide and 2-AG - are synthesized from fatty acid precursors. DHA and EPA are required substrates for this synthesis. Chronic THC use depletes endogenous cannabinoid production capacity.
WHY THIS SUBSTANCE
Supplementing the raw materials for endocannabinoid synthesis directly supports ECS recovery. This is specific to cannabis withdrawal in a way that no other common supplement is. It is why the Omega-3 is in the GREEN protocol and not the others.
This is the only compound in the protocol whose rationale is unique to cannabis. No other substance withdrawal creates the specific deficit in endocannabinoid substrate that THC use produces.
Magnesium L-Threonate
2000mg
Blood-brain barrier magnesium delivery
Magnesium L-Threonate is the only magnesium form demonstrated to cross the blood-brain barrier effectively. Once there, it supports NMDA receptor function and has been specifically studied for sleep quality and cognitive function restoration.
WHY THIS SUBSTANCE
Cannabis withdrawal's two defining features - insomnia and cognitive fog - are directly addressed by this compound. Standard magnesium forms do not reach the brain at therapeutic concentrations. This form does.
A 2016 study in Neuropharmacology showed Magnesium L-Threonate significantly improved sleep quality and reduced anxiety in subjects with suboptimal magnesium levels. The BBB penetration data distinguishes it from every other magnesium supplement.
Kudzu Root (Pueraria Lobata)
1500mg
Mesolimbic dopamine modulation
Kudzu root isoflavones modulate dopaminergic and serotonergic systems in the mesolimbic reward pathway. Three clinical trials specifically show significant reduction in alcohol consumption and craving. It reduces the reward value of alcohol, not just the craving.
WHY THIS SUBSTANCE
Alcohol addiction involves the mesolimbic dopamine system just as nicotine does - but the intervention mechanism is different. Kudzu operates on this system through a different pathway than nicotine-targeted compounds.
A 2005 Harvard Medical School study found that kudzu extract reduced alcohol consumption by 34-57% in heavy drinkers over a short-term period without behavioral intervention. This is the most clinically studied natural compound specifically for alcohol use.
Apigenin
50mg
GABA-A positive allosteric modulation
Apigenin acts as a positive allosteric modulator of GABA-A receptors - the same mechanism as benzodiazepines, but without the potency, tolerance risk, or dependency potential. It is the anxiolytic option with the best safety profile for recovery use.
WHY THIS SUBSTANCE
Cannabis withdrawal produces acute anxiety through CB1 deficiency. GABA-A support addresses this anxiety biochemically without introducing a second dependency risk. This is why apigenin rather than any prescription anxiolytic is in the GREEN protocol.
Apigenin is found naturally in chamomile. Its GABA-A modulation is well-documented. Unlike benzodiazepines, no tolerance or withdrawal syndrome has been observed at standard doses in research settings.